Limongelli John M 4
4 · Neos Therapeutics, Inc. · Filed Mar 22, 2019
Insider Transaction Report
Form 4
Limongelli John M
SVP & General Counsel
Transactions
- Award
Stock Option (Right to Buy)
2019-03-20+150,000→ 150,000 totalExercise: $3.14Exp: 2029-03-20→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]This stock option will vest in four equal, annual installments after March 18, 2019.